» Articles » PMID: 20606039

A Simple Approach to the Estimation of Incidence Rate Difference

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2010 Jul 8
PMID 20606039
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence rate difference (IRD) is a parameter of interest in many medical studies. For example, in vaccine studies, it is interpreted as the vaccine-attributable reduction in disease incidence. This is an important parameter, because it shows the public health impact of an intervention. The IRD is difficult to estimate for various reasons, especially when there are quantitative covariates or the duration of follow-up is variable. In this paper, the authors propose an approach based on weighted least-squares regression for estimating the IRD. It is very easy to implement because it boils down to performing ordinary least-squares regression analysis of transformed variables. Furthermore, if the outcome events are repeatable, the authors propose that data on all events be analyzed instead of first events only. Four versions of the Huber-White robust standard error are considered for statistical inference. Simulation studies are used to examine the performance of the proposed method. In a variety of scenarios simulated, the method provides an unbiased estimate for the IRD, and the empirical coverage proportion of the 95% confidence interval is very close to the nominal level. The method is illustrated with data from a vaccine trial carried out in the Gambia in 2001-2004.

Citing Articles

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01.

Ali M, Stockdale L, Sagara I, Zongo I, Yerbanga R, Mahamar A NPJ Vaccines. 2025; 10(1):26.

PMID: 39915506 PMC: 11802723. DOI: 10.1038/s41541-025-01078-0.


Fracture in Association with Anticoagulant Therapy in Patients with CKD and Atrial Fibrillation.

Khan N, Kim S, Lee S, Bykov K, Paik J Clin J Am Soc Nephrol. 2024; 20(1):31-38.

PMID: 39665574 PMC: 11737451. DOI: 10.2215/CJN.0000000578.


SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.

Fu E, Wexler D, Cromer S, Bykov K, Paik J, Patorno E BMJ. 2024; 385:e078483.

PMID: 38925801 PMC: 11200155. DOI: 10.1136/bmj-2023-078483.


School-based caries prevention using silver diamine fluoride: A pragmatic randomized trial in low-income rural children.

Ruff R, Niederman R medRxiv. 2024; .

PMID: 38883737 PMC: 11178007. DOI: 10.1101/2024.06.05.24308499.


A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.

Fu E, Mastrorilli J, Bykov K, Wexler D, Cervone A, Lin K Kidney Int. 2023; 105(3):618-628.

PMID: 38101515 PMC: 10922914. DOI: 10.1016/j.kint.2023.11.025.


References
1.
Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200. DOI: 10.1093/aje/kwi188. View

2.
Greenwood B . Interpreting vaccine efficacy. Clin Infect Dis. 2005; 40(10):1519-20. DOI: 10.1086/429833. View

3.
Kelly P, Lim L . Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med. 2000; 19(1):13-33. DOI: 10.1002/(sici)1097-0258(20000115)19:1<13::aid-sim279>3.0.co;2-5. View

4.
Cheung Y, Zaman S, Ruopuro M, Enwere G, Adegbola R, Greenwood B . C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health. 2008; 13(5):603-11. DOI: 10.1111/j.1365-3156.2008.02050.x. View

5.
Greenland S . Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004; 160(4):301-5. DOI: 10.1093/aje/kwh221. View